Nektar Therapeutics revenue breakdown overview

Nektar Therapeutics revenue for the last year amounted to 90.12 M USD, the most of which — 90.12 M USD — came from its highest performing source at the moment, Novel Drug Candidates, the year earlier bringing 92.06 M USD. The greatest contribution to the revenue figure was made by Rest of World — last year it brought Nektar Therapeutics 78.64 M USD, and the year before that — 82.21 M USD.